CredoScientia - Bibliothèque

Expert consensus on sequential surgery after immune-targeted conversion therapy for advanced hepatocellular carcinoma in China.

Hepatocellular carcinoma (HCC) represents a significant global health burden, particularly in the Asia-Pacific region, where it is a leading cause of cancer-related mortality. In China alone, HCC acco…

Thérapies de Conversion

Song, P., Tang, W., & Kokudo, N. (2024). Expert consensus on sequential surgery after immune-targeted conversion therapy for advanced hepatocellular carcinoma in China.. Biosci Trends, 18(6), 495-496. https://doi.org/10.5582/bst.2024.01423

01/01/2024 Lire →

A Comparative Study of Surgical Approaches for Hepatocellular Carcinoma: Conversion versus Direct Resection.

PURPOSE: The purpose of This study is exploring the intraoperative and perioperative differences between patients undergoing conversion surgery and those undergoing direct surgery, so as to improve pr…

Thérapies de Conversion

Li, X., Chen, K., Feng, X., Wu, X., Qi, S., Wang, Q., & Shi, Z. (2024). A Comparative Study of Surgical Approaches for Hepatocellular Carcinoma: Conversion versus Direct Resection.. J Hepatocell Carcinoma, 11, 2101-2113. https://doi.org/10.2147/JHC.S483397

01/01/2024 Lire →

Case report: The impact of dissociated response of immunotherapy on the treatment strategy of advanced head and neck cancer.

Some special therapeutic responses may appear during immunotherapy, such as hyperprogression, pseudoprogression and so on. Dissociated response of immunotherapy has been clinically reported in recent …

Thérapies de Conversion

Jiang, S., Li, X., & Li, J. (2024). Case report: The impact of dissociated response of immunotherapy on the treatment strategy of advanced head and neck cancer.. Front Immunol, 15, 1460480. https://doi.org/10.3389/fimmu.2024.1460480

01/01/2024 Lire →

Benefit of Conversion Therapy in Patients with Unresectable Hepatocellular Carcinoma: A Propensity Score-Matched Study.

PURPOSE: This study aimed to investigate the benefit of conversion therapy for patients with unresectable hepatocellular carcinoma (HCC).PATIENTS AND METHODS: A retrospective cohort study was conducte…

Thérapies de Conversion

Han, R., Gan, L., Sun, L., Lang, M., Tian, X., Zhu, K., Chen, L., Li, G., & Song, T. (2024). Benefit of Conversion Therapy in Patients with Unresectable Hepatocellular Carcinoma: A Propensity Score-Matched Study.. J Hepatocell Carcinoma, 11, 1835-1844. https://doi.org/10.2147/JHC.S482803

01/01/2024 Lire →

Applications of image-guided locoregional transarterial chemotherapy in patients with inoperable colorectal cancer: a review.

With the development of comprehensive treatment, locoregional transarterial chemotherapy has become an alternative conversion therapy, palliative therapy, and neoadjuvant therapy for many solid malign…

Thérapies de Conversion

Meng, W., Pan, L., Huang, L., Li, Q., & Sun, Y. (2024). Applications of image-guided locoregional transarterial chemotherapy in patients with inoperable colorectal cancer: a review.. Front Oncol, 14, 1464242. https://doi.org/10.3389/fonc.2024.1464242

01/01/2024 Lire →

Transarterial chemoembolization combined with atezolizumab plus bevacizumab conversion therapy for intermediate-stage hepatocellular carcinoma: a case report and literature review.

Hepatocellular carcinoma (HCC) ranks as the sixth most common malignancy globally, with the majority of patients presenting at the initial diagnosis with locally advanced or metastatic disease, preclu…

Thérapies de Conversion

Ai, H., Gong, T., Ma, Y., Ma, G., Ding, W., Ding, W., Wang, W., & Zhao, X. (2024). Transarterial chemoembolization combined with atezolizumab plus bevacizumab conversion therapy for intermediate-stage hepatocellular carcinoma: a case report and literature review.. Front Immunol, 15, 1358602. https://doi.org/10.3389/fimmu.2024.1358602

01/01/2024 Lire →

Efficacy and Safety of Conversion Surgery for Advanced Hepatocellular Carcinoma After Hepatic Arterial Infusion Chemotherapy.

PURPOSE: The aim of this study was to investigate the efficacy and safety of conversion surgery for advanced hepatocellular carcinoma (HCC) after hepatic arterial infusion chemotherapy (HAIC).PATIENTS…

Thérapies de Conversion

Li, W., Zheng, Z., Wang, J., Wu, T., Wang, J., Pan, Y., Chen, J., Hu, D., Xu, L., Zhang, Y., Chen, M., & Zhou, Z. (2024). Efficacy and Safety of Conversion Surgery for Advanced Hepatocellular Carcinoma After Hepatic Arterial Infusion Chemotherapy.. J Hepatocell Carcinoma, 11, 463-475. https://doi.org/10.2147/JHC.S447387

01/01/2024 Lire →

Colorectal liver metastases: Correlations of contrast-enhanced ultrasound features with tumor clinicopathological factors and clinical outcomes following conversion therapy.

OBJECTIVE: To explore the prognostic impact of contrast-enhanced ultrasound (CEUS) features for initially unresectable colorectal liver metastases (CLMs) in a clinical setting of conversion therapy.ME…

Thérapies de Conversion

Zhang, X. L., Wang, H. T., Tang, Y., Lu, Q., Yuan, H. X., Wang, X., Liu, L. H., Zhu, D. X., & Wang, W. P. (2024). Colorectal liver metastases: Correlations of contrast-enhanced ultrasound features with tumor clinicopathological factors and clinical outcomes following conversion therapy.. Clin Hemorheol Microcirc, 86(3), 339-356. https://doi.org/10.3233/CH-231963

01/01/2024 Lire →

Review of two immunosuppressants: tacrolimus and cyclosporine.

Immunosuppressants are vital in organ transplantation including facial transplantation (FT) but are associated with persistent side effects. This review article was prepared to compare the two most us…

Thérapies de Conversion

Lee, H., Myoung, H., & Kim, S. M. (2023). Review of two immunosuppressants: tacrolimus and cyclosporine.. J Korean Assoc Oral Maxillofac Surg, 49(6), 311-323. https://doi.org/10.5125/jkaoms.2023.49.6.311

31/12/2023 Lire →

Oligometastatic Gastric Cancer: Clinical Data from the Meta-Gastro Prospective Register of the Italian Research Group on Gastric Cancer.

BACKGROUND: Interest in the field of metastatic gastric cancer has grown in recent years, and the identification of oligometastatic patients plays a critical role as it consents to their inclusion in …

Thérapies de Conversion

Bencivenga, M., Ministrini, S., Morgagni, P., Mura, G., Marrelli, D., Milandri, C., Mazzei, M. A., Berselli, M., Monti, M., Graziosi, L., Reddavid, R., Rosa, F., Solaini, L., Donini, A., Fumagalli, R. o. m. a. r. i. o. . U., Roviello, F., de, M. a. n. z. o. n. i. . G., & Tiberio, G. A. M. (2023). Oligometastatic Gastric Cancer: Clinical Data from the Meta-Gastro Prospective Register of the Italian Research Group on Gastric Cancer.. Cancers (Basel), 16(1). https://doi.org/10.3390/cancers16010170

29/12/2023 Lire →

PD-L1 inhibitor plus gemcitabine and cisplatin therapy followed by conversion surgery for initially unresectable advanced gallbladder cancer.

Advanced gallbladder cancer (GBC) is not amenable to surgical resection. There are limited treatment options and the prognosis is dismal. The role of immune checkpoint inhibitors in conversion therapy…

Thérapies de Conversion

Zhang, S., Nie, J., Tai, S., & Zheng, T. (2023). PD-L1 inhibitor plus gemcitabine and cisplatin therapy followed by conversion surgery for initially unresectable advanced gallbladder cancer.. BMJ Case Rep, 16(12). https://doi.org/10.1136/bcr-2023-255403

20/12/2023 Lire →

Chinese expert consensus on the overall management of liver function in conversion therapy for liver cancer (2022 edition).

Thérapies de Conversion

Meng, Q., Yang, Z., Zhu, Z., Li, J., Bi, X., Chen, X., Hao, C., Huang, Z., Li, F., Li, X., Li, G., Yang, Y., Zhang, Y., Zhao, H., Zhao, H., Zhu, X., Zhu, J., Cai, J., Liver, T. u. m. o. r. . B. r. a. n. c. h. . o. f. . t. h. e. . C. h. i. n. a. . I. n. t. e. r. n. a. t. i. o. n. a. l. . E. x. c. h. a. n. g. e. . a. n. d. . P. r. o. m. o. t. i. v. e. . A. s. s. o. c. i. a. t. i. o. n. . f. o. r. . M. e. d. i. c. a. l. . a. n. d. . H. e. a. l. t. h. c. a. r. e. . (. C. P. A. M. )., … Liver, C. a. n. c. e. r. . P. r. o. f. e. s. s. i. o. n. a. l. . C. o. m. m. i. t. t. e. e. . o. f. . C. h. i. n. e. s. e. . M. e. d. i. c. a. l. . D. o. c. t. o. r. . A. s. s. o. c. i. a. t. i. o. n. (2023). Chinese expert consensus on the overall management of liver function in conversion therapy for liver cancer (2022 edition).. Chin Med J (Engl), 136(24), 2909-2911. https://doi.org/10.1097/CM9.0000000000002950

20/12/2023 Lire →